J-pharma Co., Ltd.
Clinical trials sponsored by J-pharma Co., Ltd., explained in plain language.
-
New hope for bile duct cancer: experimental drug enters final testing phase
Disease control Recruiting nowThis study tests a new drug called nanvuranlat in 480 adults with advanced biliary tract cancer (bile duct cancer) that has already been treated. The goal is to see if nanvuranlat helps people live longer compared to standard treatments like chemotherapy or best supportive care. …
Phase: PHASE3 • Sponsor: J-Pharma Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New drug JPH034 enters first human safety tests
Knowledge-focused Recruiting nowThis early-stage study is testing a new drug, JPH034, in 40 healthy adults aged 18 to 50. Participants receive either the drug or a placebo once (and some a second time with food) to check for side effects and measure how the drug moves through the body. The goal is to gather saf…
Phase: PHASE1 • Sponsor: J-Pharma Co., Ltd. • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC